The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
TGF-β-induced epithelial to mesenchymal transition
Open accessAbstract
During development and in the context of different morphogenetic events, epithelial cells undergo a process called epithelial to mesenchymal transition or transdifferentiation (EMT). In this process, the cells lose their epithelial characteristics, including their polarity and specialized cell-cell contacts, and acquire a migratory behavior, allowing them to move away from their epithelial cell community and to integrate into surrounding tissue, even at remote locations. EMT illustrates the differentiation plasticity during development and is complemented by another process, called mesenchymal to epithelial transition (MET). While being an integral process during development, EMT is also recapitulated under pathological conditions, prominently in fibrosis and in invasion and metastasis of carcinomas. Accordingly, EMT is considered as an important step in tumor progression. TGF-beta signaling has been shown to play an important role in EMT. In fact, adding TGF-beta to epithelial cells in culture is a convenient way to induce EMT in various epithelial cells. Although much less characterized, epithelial plasticity can also be regulated by TGF-beta-related bone morphogenetic proteins (BMPs), and BMPs have been shown to induce EMT or MET depending on the developmental context. In this review, we will discuss the induction of EMT in response to TGF-beta, and focus on the underlying signaling and transcription mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“EMT plays an important role in cancer progression and is induced by TGFβ [23].”
The cited source says what the claim attributes to it.
In the citing paper
“Adding TGF-β induces EMT in diverse epithelial cell cultures via the SMAD signaling pathway (56).”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Han, S., Ritzenthaler, J. D., Sitaraman, S. V., & Roman, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604013200 · Cited by 98
RetractedSmad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498
Self-citationTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R., Côme, C., Savagner, P., Gitelman, I., Richardson, A. L., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,917
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew‐Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,852
Cano, A., Pérez‐Moreno, M., Rodrigo, I., Locascio, A., Blanco, M. J., Barrio, M. G. D., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,672
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
Batlle, E., Sancho, E., Francı́, C., Dominguez-Sola, D., Monfar, M., Baulida, J., & de Herreros, A. G. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,671
Multifunctional strands in tight junctions
Tsukita, S., Furuse, M., & Itoh, M. (2001) · Nature reviews. Molecular cell biology · doi:10.1038/35067088 · Cited by 2,578
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,537
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Akhurst R . TGF-β signaling in epithelial-mesenchymal transition and invasion and metastasis. In: Derynck R, Miyazono K, eds. The TGF-beta family. Cold Spring Harbor Laboratory Press: New York 2007:939–964.
Cited by
Sorted by citations
Items 701–800 of 1,008
In vivo effects of adjunctive tetracycline treatment on refractory corneal ulcers in dogs
Chandler, H. L., Gemensky‐Metzler, A. J., Bras, I. D., Webb, T. E. R., Saville, W. J. A., & Colitz, C. M. H. (2010) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.237.4.378 · Cited by 50
Role of Signaling Pathways in Mesenchymal Stem Cell Differentiation
Birru, B., Mekala, N. K., Baadhe, R. R., & Rao, P. S. (2014) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x09666140812112002 · Cited by 50
Transforming Growth Factor type β and Smad family signaling in stem cell function
Seuntjens, E., Umans, L., Zwijsen, A., Sampaolesi, M., Verfaillie, C. M., & Huylebroeck, D. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.10.005 · Cited by 50
P68 RNA helicase as a molecular target for cancer therapy
Dai, T.-Y., Cao, L., Yang, Z., Li, Y., Tan, L., Ran, X., & Shi, C. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/preaccept-9737114991295403 · Cited by 50
Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Margaritopoulos, G. A., Romagnoli, M., Poletti, V. E., Siafakas, N. M., Wells, A. U., & Antoniou, K. M. (2012) · European Respiratory Review · doi:10.1183/09059180.00007611 · Cited by 50
Li, X., Yu, X., Dai, D., Song, X., & Xu, W. (2016) · Oncotarget · doi:10.18632/oncotarget.8153 · Cited by 53
Cancer Stem Cells and Metastasis
Nandy, S., & Lakshmanaswamy, R. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.07.007 · Cited by 50
Matrix remodeling in chronic lung diseases
Gu, B., Madison, M. C., Corry, D. B., & Kheradmand, F. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.012 · Cited by 52
Karedath, T., Ahmed, I., Ameri, W. A., Al-Dasim, F. M., Andrews, S., Samuel, S. M., Al-Azwani, I. K., Mohamoud, Y. A., Rafii, A., & Malek, J. A. (2019) · BMC Cancer · doi:10.1186/s12885-019-5723-0 · Cited by 50
Citro, S., Bellini, A., Miccolo, C., Ghiani, L., Carey, T. E., & Chiocca, S. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0394-9 · Cited by 49
Cumin, C., Huang, Y., Everest‐Dass, A., & Jacob, F. (2021) · Biomolecules · doi:10.3390/biom11010062 · Cited by 49
Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases
Sarrand, J., & Soyfoo, M. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914481 · Cited by 50
Ebrahimi, N., Manavi, M. S., Faghihkhorasani, F., Fakhr, S. S., Baei, F. J., Khorasani, F. F., Zare, M. M., Far, N. P., Rezaei‐Tazangi, F., Ren, J. T., et al. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10162-7 · Cited by 50
Dong, S., Fang, H., Zhu, J., Wu, Z., Liu, Y., Zhu, J., Ma, B., Chen, Q., & Yang, Y. (2025) · ACS Nano · doi:10.1021/acsnano.4c15130 · Cited by 51
Dalmau, N., Jaumot, J., Tauler, R., & Bedia, C. (2015) · Molecular BioSystems · doi:10.1039/c5mb00413f · Cited by 49
Dutta, B., Pusztai, L., Qi, Y., André, F., Lazar, V., Bianchini, G., Ueno, N. T., Agarwal, R., Wang, B., Shiang, C. Y., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.584 · Cited by 52
Winitthana, T., Lawanprasert, S., & Pithi Chanvorachote, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110851 · Cited by 49
Жао, Л., Liu, S., Che, X., Hou, K., Ma, Y., Li, C., Wen, T., Fan, Y., Hu, X., Liu, Y., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2268 · Cited by 49
Ting, H., Deep, G., Kumar, S., Jain, A., Agarwal, C., & Agarwal, R. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw039 · Cited by 49
Iqbal, W., Alkarim, S., Al-Hejin, A. M., Mukhtar, H., & Saini, K. S. (2016) · Oncotarget · doi:10.18632/oncotarget.10942 · Cited by 50
Tang, W., Du, L., Sun, W. C., Yu, Z., He, F., Chen, J., Li, X., Li, X., Yu, L., & Chen, D. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.12.016 · Cited by 49
Reprogramming to developmental plasticity in cancer stem cells
O’Brien‐Ball, C., & Biddle, A. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.07.025 · Cited by 51
Elaskalani, O., Falasca, M., Moran, N. M., Berndt, M., & Metharom, P. (2017) · Cancers · doi:10.3390/cancers9100142 · Cited by 49
Expression of PRDX6 Correlates with Migration and Invasiveness of Colorectal Cancer Cells
Huang, W., Huang, C.-Y., Hsieh, M., Kuo, Y.-H., Tung, S., Shen, C., Hsieh, Y., Teng, C., Lee, K., Lee, K.-F., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495934 · Cited by 49
Liao, S., Luo, J., Li, D., Zhou, Y., Yan, B., Wei, J., Tu, J., Li, Y., Zhang, G., & Feng, Z. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-019-00508-8 · Cited by 49
Zhang, Y., Huang, Q., Chen, Y., Xuan, P., Wang, Y., Li, S., Wu, J., Luo, C., Gong, W., Yin, B., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106064 · Cited by 49
Lourenço, A. R., Roukens, M. G., Seinstra, D., Frederiks, C. L., Pals, C. E. G. M., Vervoort, S. J., Margarido, A. S., van Rheenen, J., & Coffer, P. J. (2020) · Nature Communications · doi:10.1038/s41467-020-14556-x · Cited by 49
Tong, X., Wang, S., Lei, Z., Li, C., Zhang, C., Su, Z., Liu, X., Zhao, J., & Zhang, H. (2020) · Oncogene · doi:10.1038/s41388-020-1189-4 · Cited by 49
O’Brien, S. J., Bishop, C., Hallion, J. C., Fiechter, C. R., Scheurlen, K. M., Paas, M., Burton, J. F., & Galandiuk, S. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1794239 · Cited by 49
Xu, F., Shangguan, X., Pan, J., Yue, Z., Shen, K., Ji, Y., Zhang, W., Zhu, Y., Sha, J., Wang, Y., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33494 · Cited by 49
Role of Glycans on Key Cell Surface Receptors That Regulate Cell Proliferation and Cell Death
Gao, Y. H., Luan, X., Melamed, J., & Brockhausen, I. (2021) · Cells · doi:10.3390/cells10051252 · Cited by 49
Chandrasekaran, V., Carta, G., Pereira, D. D. C., Gupta, R., Murphy, C., Feifel, E., Kern, G., Lechner, J., Cavallo, A. L., GUPTA, S. K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-89550-4 · Cited by 49
Epithelial to Mesenchymal Transition History: From Embryonic Development to Cancers
Lachat, C., Peixoto, P., & Hervouet, É. (2021) · Biomolecules · doi:10.3390/biom11060782 · Cited by 52
Bai, X., Li, Y., Zhang, H., Wang, F., He, H., Yao, J.-C., Liu, L., & Li, S. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s134813 · Cited by 49
Translation initiation: a critical signalling node in cancer
Robert, F., & Pelletier, J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903241625 · Cited by 48
Biological influence of Hakai in cancer: a 10-year review
Aparicio, L. A., Valladares, M., Blanco, M., Alonso, G., & Figueroa, A. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9348-x · Cited by 48
BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma
Duangkumpha, K., Techasen, A., Loilome, W., Namwat, N., Thanan, R., Khuntikeo, N., & Yongvanit, P. (2014) · Tumor Biology · doi:10.1007/s13277-014-2246-9 · Cited by 48
Fu, J., KE, X., Tan, S., Liu, T., Wang, S., Ma, J., & Lu, H. (2015) · Oncology Reports · doi:10.3892/or.2015.4394 · Cited by 49
Yoshida, K., Murata, M., Yamaguchi, T., Matsuzaki, K., & Okazaki, K. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5010007 · Cited by 48
Chen, C., Chen, Y., Tai, M., Liang, C., Lu, D., & Chen, J. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s126743 · Cited by 48
Increased Hemodynamic Load in Early Embryonic Stages Alters Endocardial to Mesenchymal Transition
Midgett, M., López, C. S., David, L. L., Maloyan, A., & Rugonyi, S. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00056 · Cited by 48
Ruan, H., Yang, H., Wei, H., Xiao, W., Lou, N., Qiu, B., Xu, G., Song, Z., Xiao, H., Liu, L., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4010 · Cited by 48
Physical oncology: New targets for nanomedicine
Nicolás‐Boluda, A., Silva, A., Fournel, S., & Gazeau, F. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.014 · Cited by 48
Metabolism and mechanisms of action of hyaluronan in human biology
Joy, R. A., Vikkath, N., & Ariyannur, P. S. (2018) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2017-0031 · Cited by 48
Abudureheman, A., Ainiwaer, J., Hou, Z., Niyaz, M., Turghun, A., Hasim, A., Zhang, H., Lu, X., & Sheyhidin, I. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2625-5 · Cited by 50
Qiao, Y., Wang, Z., Tan, F., Chen, J., Lin, J., Yang, J., Li, H., Wang, X., Šali, A., Zhang, L., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.05.026 · Cited by 49
Yang, Y. M., Lee, W. H., Lee, C. G., An, J., Kim, E.-S., Kim, S. H., Lee, S.-K., Lee, C. H., Dhanasekaran, D. N., Moon, A., et al. (2014) · Oncogene · doi:10.1038/onc.2014.218 · Cited by 47
Zhang, S., Guo, Y., Cui, Y., Liu, Y., Yu, T., & Wang, H. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9552-x · Cited by 47
Two sides of the same coin: stem cells in cancer and regenerative medicine
Ilmer, M., Vykoukal, J. V., Boiles, A. R., Coleman, M., & Alt, E. (2014) · The FASEB Journal · doi:10.1096/fj.13-244640 · Cited by 48
Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer
Chung, I., Chen, C.-Y., Lin, Y.-H., Chi, H., Huang, Y., Tai, P.-J., Liao, C., Tsai, C., Lin, S.-L., Wu, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3670 · Cited by 47
PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway
Yang, Z., Liu, S., Zhu, M., Zhang, H., Wang, J., Xu, Q., Lin, K., Zhou, X., Tao, M., Li, C., et al. (2016) · Scientific Reports · doi:10.1038/srep22090 · Cited by 47
Sakata, J., Utsumi, F., Suzuki, S., Niimi, K., Yamamoto, E., Shibata, K., Senga, T., Kikkawa, F., & Kajiyama, H. (2017) · Oncotarget · doi:10.18632/oncotarget.20107 · Cited by 47
Zhao, J., Wu, Z.-H., Guo, J., Huang, M.-J., You, Y.-Z., Liu, H., & Huang, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.023 · Cited by 47
Karoii, D. H., Azizi, H., & Amirian, M. (2022) · Cellular Reprogramming · doi:10.1089/cell.2022.0025 · Cited by 47
Disabled-2 downregulation promotes epithelial-to-mesenchymal transition
Martin, J., Herbert, B.-S., & Hocevar, B. A. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605975 · Cited by 47
Ramundo, V., Zanirato, G., & Aldieri, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212216 · Cited by 46
Hashemi, M., Hajimazdarany, S., Mohan, C. D., Mohammadi, M., Rezaei, S., Olyaee, Y., Goldoost, Y., Ghorbani, A., Mirmazloomi, S. R., Gholinia, N., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106535 · Cited by 46
Somanader, D. V. N., Zhao, P., Widdop, R. E., & Samuel, C. S. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116130 · Cited by 50
Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer
Lee, H., Lee, D., & Park, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1118-z · Cited by 46
Upadhyay, S. K., Verone, A. R., Shoemaker, S. F., Qin, M., Liu, S., Campbell, M. J., & Hershberger, P. A. (2013) · Cancers · doi:10.3390/cancers5041504 · Cited by 46
Santibanez, J. F., Krstić, J., Fabra, À., Cano, A., & Quintanilla, M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.042 · Cited by 46
Tang, M., Shen, H., Jin, Y., Lin, T., Cai, Q., Pinard, M. A., Biswas, S., Tran, Q., Li, G., Shenoy, A. K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482349 · Cited by 46
New molecular medicine-based scar management strategies
Arno, A. I., Gauglitz, G. G., Barret, J. P., & Jeschke, M. G. (2014) · Burns · doi:10.1016/j.burns.2013.11.010 · Cited by 46
Tristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cells
Yoon, N. A., Jo, H. G., Lee, U. H., Park, J. H., Yoon, J. E., Ryu, J., Kang, S. S., Min, Y. J., Ju, S., Seo, E. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7094 · Cited by 46
Powell, C. D., Paullin, T., Aoisa, C., Menzie, C., Ubaldini, A., & Westerheide, S. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168389 · Cited by 46
Harner-Foreman, N., Vadakekolathu, J. N., Laversin, S. A., Mathieu, M. G., Reeder, S., Pockley, A. G., Rees, R. C., & Boocock, D. J. (2017) · Scientific Reports · doi:10.1038/srep40633 · Cited by 46
Okato, A., Arai, T., Kojima, S., Koshizuka, K., Osako, Y., Idichi, T., Kurozumi, A., Goto, Y., Kato, M., Naya, Y., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4008 · Cited by 46
Chen, C., Ma, T., Zhang, C., Zhang, H., Bai, L., Kong, L., & Luo, J. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22712 · Cited by 46
Huang, D., Zheng, C., Pan, Q., Wu, S., Su, X., Li, L., Wu, J., & Sun, Z. (2018) · Scientific Reports · doi:10.1038/s41598-017-18869-8 · Cited by 46
Sharma, S., Goswami, R., & Rahaman, S. O. (2018) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-018-00565-w · Cited by 46
Zou, Y., Li, S., Li, Z., Song, D., Zhang, S., & Yao, Q. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.01.012 · Cited by 46
Annaldas, S., Saifi, M. A., Khurana, A., & Godugu, C. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.06.003 · Cited by 46
Overexpression of Extradomain-B Fibronectin is Associated with Invasion of Breast Cancer Cells
Vaidya, A. M., Wang, H., Qian, V., Gilmore, H. L., & Lu, Z. (2020) · Cells · doi:10.3390/cells9081826 · Cited by 46
Wu, D., Kanda, A., Liu, Y., Noda, K., Murata, M., & Ishida, S. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.14.29 · Cited by 46
Quantitative and Multiplexed Fluorescence Lifetime Imaging of Intercellular Tensile Forces
Keshri, P., Zhao, B., Xie, T., Bagheri, Y., Chambers, J. J., Sun, Y., & You, M. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202103986 · Cited by 46
Tewari, D., Priya, A., Bishayee, A., & Bishayee, A. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.795 · Cited by 46
Kim, Y.-B., Ahn, Y.-H., Jung, J.-H., Lee, Y.-J., Lee, J.-H., & Kang, J. L. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0209-1 · Cited by 45
TGF-beta: a master switch in tumor immunity
Gigante, M., Gesualdo, L., & Ranieri, E. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802430378 · Cited by 45
Endothelial-to-Mesenchymal Transition: Role in Cardiac Fibrosis
Cheng, W., Li, X., Liu, D., Cui, C., & Wang, X. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420952233 · Cited by 45
Xiong, C., Zhu, Y., Xue, M., Jiang, Y., Zhong, Y., Jiang, L., Shi, M., & Chen, H. (2021) · Aging · doi:10.18632/aging.202264 · Cited by 45
Zhang, S., Fan, Y., Qin, L., Fang, X., Zhang, C., Yue, J., Bai, W., Wang, G., Chen, Z. H., Renz, H., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01808-7 · Cited by 45
Ko, H., Jeon, H., Lee, D., Choi, H., Kang, K. S., & Choi, K. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.067 · Cited by 45
Yao‐Borengasser, A., Monzavi‐Karbassi, B., Hedges, R. A., Rogers, L. J., Kadlubar, S. A., & Kieber‐Emmons, T. (2015) · Oncology Reports · doi:10.3892/or.2015.3880 · Cited by 46
Characterization of LMX‐1A as a metastasis suppressor in cervical cancer
Liu, C., Chao, T., Su, P., Lee, H., Shih, Y., Su, H., Chu, T., Yu, M., Lin, Y., & Lai, H. (2009) · The Journal of Pathology · doi:10.1002/path.2589 · Cited by 45
Zhu, Y., Nilsson, M., & Sundfeldt, K. (2010) · Endocrinology · doi:10.1210/en.2010-0486 · Cited by 45
Protein Kinase D Enzymes as Regulators of EMT and Cancer Cell Invasion
Durand, N., Borgés, S., & Störz, P. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020020 · Cited by 45
Jeon, Y. J., Jung, N., Park, J., Park, H., & Jung, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136442 · Cited by 45
Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells
Liu, S., Zhou, F., Shen, Y., Zhang, Y., Yin, H., Zeng, Y., Liu, J., Yan, Z., & Liu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.8765 · Cited by 45
Yoon, Y.-S., Lee, Y.-J., Choi, Y., Park, Y. M., & Kang, J. L. (2016) · Scientific Reports · doi:10.1038/srep20992 · Cited by 45
Taiyab, A., Korol, A. S., Deschamps, P. A., & West‐Mays, J. A. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20162 · Cited by 46
Rodríguez-Mateo, C., Torres, B., Gutiérrez, G., & Pintor‐Toro, J. A. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.9 · Cited by 45
Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells
Mitrović, A., Fonović, U. P., & Kos, J. (2017) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2017.04.003 · Cited by 45
Towards control of cellular decision-making networks in the epithelial-to-mesenchymal transition
Zañudo, J. G. T., Guinn, M. T., Farquhar, K. S., Szenk, M., Steinway, S. N., Balázsi, G., & Albert, R. (2019) · Physical Biology · doi:10.1088/1478-3975/aaffa1 · Cited by 47
GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines
Cultrara, C. N., Kozuch, S. D., Ramasundaram, P., Heller, C. J., Shah, S. S., Beck, A. E., Sabatino, D. A., & Zilberberg, J. (2018) · BMC Cancer · doi:10.1186/s12885-018-5178-8 · Cited by 45
Haddad, A., Gaudet, M., Plesa, M., Allakhverdi, Z., Mogas, A. K., Audusseau, S., Baglole, C. J., Eidelman, D. H., Olivenstein, R., Ludwig, M. S., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1186-8 · Cited by 45
Ghafar, M. T. A., Morad, M. A., El-Zamarany, E. A., Ziada, D. H., Soliman, H. H., Abd-Elsalam, S. M., & Salama, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106375 · Cited by 45
EMT‐Induced Cell‐Mechanical Changes Enhance Mitotic Rounding Strength
Hosseini, K., Taubenberger, A. V., Werner, C., & Fischer‐Friedrich, E. (2020) · Advanced Science · doi:10.1002/advs.202001276 · Cited by 45
Pei, H., Guo, W., Peng, Y., Xiong, H., & Chen, Y. (2022) · Medicinal Research Reviews · doi:10.1002/med.21886 · Cited by 45
Li, J., Ballim, D., Rodriguez, M., Cui, R., Goding, C. R., Teng, H., & Prince, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.596411 · Cited by 44
De, S., Das, S., Mukherjee, S., Das, S., & Sengupta, S. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.10.005 · Cited by 44
Metadata
- Authors
- Xu, J., Lamouille, S., & Derynck, R.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Derynck, Rik
- Venue
- Cell Research
- Published
- 2009-01-20
- Volume
- 19
- Issue
- 2
- Pages
- 156-172
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- PMC
- PMC4720263
- OpenAlex
- W1760215417
- Cited by
- 2,804
- References
- 167
- Citations by year
- 2026: 123 · 2025: 178 · 2024: 186 · 2023: 207 · 2022: 252 · 2021: 242 · 2020: 220 · 2019: 174 · 2018: 190 · 2017: 197 · 2016: 162 · 2015: 148 · 2014: 149 · 2013: 111 · 2012: 95
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL060231)
- National Center for Research Resources (P41RR001614)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- epithelial-mesenchymal transition, TGF-beta signaling, mesenchymal-epithelial transition, epithelial plasticity, bone morphogenetic proteins, cell migration, tumor progression, fibrosis, tumor invasion and metastasis, cell polarity, transcriptional regulation
- MeSH terms
- Epithelial Cells, Mesoderm, Transcription Factors, Signal Transduction, Transforming Growth Factor beta, Bone Morphogenetic Proteins, Smad Proteins, Cell Transdifferentiation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review